Professional
Added to YB: 2026-06-22
Pitch date: 2026-03-31
ACUTAAS.NS [bullish]
Acutaas Chemicals Limited
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
Market Cap
INR 265.8B
Pitch Price
N/A
Price Target
N/A
Dividend
0.08%
EV/EBITDA
55.05
P/E
74.85
EV/Sales
19.74
Sector
Pharmaceuticals
Category
growth
Show full summary:
Baron India Fund Added On Position: Acutaas Chemicals Limited
ACUTAAS.NS (added to position): Leading Indian maker of advanced pharma intermediates/specialty chems; 50-90% share in critical pre-API intermediates. Scaling higher-margin CDMO (key vendor for Bayer's darolutamide, >$4B peak sales). New electrolyte/semi chem ventures. Sees 20%+ rev/EPS CAGR over 3-5yrs.
Read full article (1 min)